Global Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters Devices Pipeline Report 2021: Product Description, Licensing and Collaboration Details, Developmental Activities

Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive information about the Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters segment includes Standard Balloon Catheters and PTA Peripheral DCB Catheters. PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries. Standard Balloon Catheters are used to open up the arteries that are blocked by plaque build-up (atherosclerosis).

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters under development

• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

• The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters and list all their pipeline projects

• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

• The report provides key clinical trial data of ongoing trials specific to pipeline products

• Recent developments in the segment / industry

Key Topics Covered:

1 Tables & Figures

2 Introduction
2.1 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters Overview

3 Products under Development
3.1 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Stage of Development
3.2 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Segment
3.3 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Territory
3.4 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Regulatory Path
3.5 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Estimated Approval Date
3.6 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Ongoing Clinical Trials

4 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products under Development by Companies
4.1 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters Companies - Pipeline Products by Stage of Development
4.2 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Pipeline Products by Stage of Development

5 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters Companies and Product Overview
5.1 Andramed GmbH Company Overview
5.2 AnGes Inc Company Overview
5.3 AngioCure, Inc. Company Overview
5.4 Ascenion GmbH Company Overview
5.5 Boston Scientific Corp Company Overview
5.6 Cardionovum GmbH Company Overview
5.7 Cardiovascular Systems Inc Company Overview
5.8 Chansu Vascular Technologies LLC Company Overview
5.9 Concept Medical Inc Company Overview
5.10 Contego Medical LLC Company Overview
5.11 Endocor GmbH Company Overview
5.12 eucatech AG Company Overview
5.13 Genesis MedTech International Pvt Ltd Company Overview
5.14 Hexacath SA Company Overview
5.15 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.16 Lutonix Inc Company Overview
5.17 M.A. Med Alliance SA Company Overview
5.18 Medtronic Plc Company Overview
5.19 Micell Technologies Inc Company Overview
5.20 NuVascular Technologies Inc Company Overview
5.21 OrbusNeich Company Overview
5.22 Orchestra BioMed Inc Company Overview
5.23 Pulsus Medical LLC (Inactive) Company Overview
5.24 QT Vascular Ltd Company Overview
5.25 QualiMed Innovative Medizinprodukte GmbH Company Overview
5.26 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
5.27 Shockwave Medical Inc Company Overview
5.28 SiL Vascular Ltd Company Overview
5.29 Spectranetics Corp Company Overview
5.30 Stemplant LLC Company Overview
5.31 SurModics Inc Company Overview
5.32 Suzhou Tianhong Shengjie Medical Co Ltd Company Overview
5.33 Tailored Medical Devices Inc Company Overview
5.34 Transit Scientific LLC Company Overview
5.35 TransMed7 LLC Company Overview
5.36 Vascular Nanotransfer Technologies Company Overview
5.37 Zylox-Tonbridge Medical Technology Co Ltd Company Overview

6 Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters - Recent Developments
6.1 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
6.2 Sep 01, 2021: Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
6.3 Aug 26, 2021: Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference
6.4 Aug 13, 2021: QT Vascular Announces Condensed Interim Financial Statements for the six months ended 30 June 2021
6.5 Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
6.6 Jul 30, 2021: QT Vascular Announces Appointment of Independent Director
6.7 Jul 29, 2021: Edwards Lifesciences Announces financial results for the quarter ended June 30, 2021
6.8 Jul 27, 2021: Cardiovascular Systems to Attend Three Investor Conferences in August
6.9 Jul 27, 2021: Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4
6.10 Jul 22, 2021: Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021
6.11 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
6.12 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
6.13 May 05, 2021: Edwards Announces Updates From Annual Meeting
6.14 Apr 30, 2021: QT Vascular Announces Results of Annual General Meeting Held on 30 April 2021
6.15 Apr 29, 2021: Teleflex Reports First Quarter 2021 Results
6.16 Apr 15, 2021: Qt Vascular announces Annual General Meeting
6.17 Mar 26, 2021: Qt Vascular announce Financial Statements
6.18 Mar 24, 2021: Cardiovascular Systems to Participate at the 20th Annual Needham Healthcare Conference
6.19 Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems
6.20 Mar 10, 2021: Teleflex to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
6.21 Feb 22, 2021: Daiichi Sankyo Appoints Ken Takeshita, MD as Global Head of R&D
6.22 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
6.23 Feb 16, 2021: Teleflex to Present at the Raymond James 42nd Annual Institutional Investors Conference
6.24 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.25 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
6.26 Feb 11, 2021: Teleflex Announces Fourth Quarter and Full Year 2020 Earnings Conference Call Information
6.27 Feb 09, 2021: Surmodics Reports First Quarter Fiscal 2021 Results
6.28 Feb 04, 2021: Terumo announce Financial Statements
6.29 Feb 03, 2021: Cardiovascular Systems, Inc. Reports Fiscal 2021 Second-quarter Financial Results
6.30 Feb 01, 2021: Surmodics to Webcast First Quarter Fiscal 2021 Earnings Conference Call on February 9
6.31 Feb 01, 2021: Cardiovascular Systems announces partnership with Chansu Vascular to develop new drug-coated balloon technology
6.32 Jan 13, 2021: Edwards Lifesciences To Host Earnings Conference Call On January 27, 2021

For more information about this report visit https://www.researchandmarkets.com/r/8kovua

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900